Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Concord Medical Services Holdings Limited (CCM)

Compare
4.4000
+0.4000
+(10.00%)
At close: April 1 at 1:45:14 PM EDT
4.4000
0.00
(0.00%)
After hours: April 1 at 5:49:49 PM EDT
Loading Chart for CCM
  • Previous Close 4.0000
  • Open 3.9000
  • Bid 4.1000 x 1300
  • Ask 15.5100 x 2200
  • Day's Range 3.9000 - 4.4000
  • 52 Week Range 3.8000 - 26.7000
  • Volume 5,921
  • Avg. Volume 10,721
  • Market Cap (intraday) 19.104M
  • Beta (5Y Monthly) -0.49
  • PE Ratio (TTM) --
  • EPS (TTM) -11.9400
  • Earnings Date Apr 16, 2025 - Apr 23, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 23, 2015
  • 1y Target Est --

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

www.concordmedical.com

727

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CCM

View More

Performance Overview: CCM

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

CCM
21.43%
MSCI WORLD (^990100-USD-STRD)
1.62%

1-Year Return

CCM
15.38%
MSCI WORLD (^990100-USD-STRD)
7.18%

3-Year Return

CCM
73.33%
MSCI WORLD (^990100-USD-STRD)
19.33%

5-Year Return

CCM
72.84%
MSCI WORLD (^990100-USD-STRD)
102.31%

Compare To: CCM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CCM

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    17.37M

  • Enterprise Value

    463.05M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    7.13

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -80.33%

  • Return on Assets (ttm)

    -4.40%

  • Return on Equity (ttm)

    -32.40%

  • Revenue (ttm)

    471.7M

  • Net Income Avi to Common (ttm)

    -378.93M

  • Diluted EPS (ttm)

    -11.9400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    326.9M

  • Total Debt/Equity (mrq)

    185.55%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: CCM

View More

Company Insights: CCM

Research Reports: CCM

View More

People Also Watch